The S100A8/A9 complex is highly expressed in both human and mouse atherosclerotic lesions (Croce et al. 2009; Eue et al. 2000), and promotes atherosclerosis in diabetic patients (Kraakman et al. 2017). Here, IGKV1D-22 is linked to atherosclerosis.